Company / Cash per Share
Cullinan Therapeutics, Inc. Cash per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.42
FY2024
5-year range
$1.42 / $8.46
FY2020-FY2024
Trend
-40.1%
vs FY2023
Sector context
#132 of 205
Health Care
What the data says
At $1.42, Cullinan Therapeutics, Inc.'s cash per share ranks #132 of 205 in the Health Care sector. Declined from $3.41 to $1.42 over the past 2 years.
Based on SEC 10-K filings.
1.42 in FY2024 with a 3-year CAGR of -10.9%.
Declined from $3.41 to $1.42 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -10.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#132 of 205 in Health CareTop 64% of 205This company $1.42 Sector average $72.94
▼
-98.1% below sector average
Key checks
Key Insights
- In FY2024, cash per share decreased 40.1% year-over-year.
- Ranks #132 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 7.33 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.42 | -40.1% |
| FY2023 | $2.37 | -30.5% |
| FY2022 | $3.41 | +70.2% |
| FY2021 | $2.00 | -76.3% |
| FY2020 | $8.46 | - |
As of FY2024 · SEC 10-K · Updated Jul 2, 2026